Ifupinostat (BEBT-908) is a blood-brain barrier-permeable PI3K/HDAC inhibitor. Ifupinostat exerts anticancer activity against hematologic malignancies, lung cancer, colon cancer, brain cancer and other cancers. Ifupinostat inhibits the PI3K/AKT/mTOR signaling pathway, suppresses c-Myc expression and induces ferroptosis. Ifupinostat can be used in tumor research[1].
Molecular Weight:
507.57
Purity:
99.30
CAS Number:
[1235449-52-1]
Formula:
C23H25N9O3S
Target:
Akt,c-Myc,Ferroptosis,Histone Acetyltransferase,mTOR,PI3K,Reactive Oxygen Species (ROS)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted